We exist to improve the lives
of everyone affected by epilepsy

Epilepsy Today

Diazepam 2.5mg RecTubes (rectal diazepam) out of stock in UK

4 Dec 2018

Diazepam 2.5mg RecTubes (rectal diazepam) are out of stock. The maker of RecTubes, Wockhardt, has told us this is due to a manufacturing issue. Wockhardt does not know when it will have them back in stock.

Other doses of rectal diazepam are in stock.

We are not aware of any other companies in the UK that make a 2.5mg dose of rectal diazepam. If you or your child has been prescribed this dose, speak to your GP, epilepsy specialist or epilepsy specialist nurse for advice.

Carbagen SR out of stock in the UK

30 Nov 2018

Carbagen SR (prolonged release carbamazepine) tablets are out of stock in all doses. This is due to a long-term manufacturing issue. Mylan, the maker of Carbagen SR, does not know when it will have these tablets back in stock.

Standard release Carbagen tablets are not affected by the manufacturing issue and are in stock. Other manufacturer’s versions of prolonged release carbamazepine are also in stock.

If you have any concerns about taking a different version of your medicine, speak to your GP, epilepsy nurse or epilepsy specialist.

Epilim Chronosphere MR (sodium valproate) 250mg granules out of stock in UK

23 Nov 2018

Update on 23 November 2018

This medicine is now back in stock.

Original story 30 October 2018

Epilim Chronosphere MR 250mg granules are temporarily out of stock. The maker of Epilim Chronosphere, Sanofi, expects to have them back in stock from 30 November 2018.

Other doses of Epilim Chronosphere are available. But Sanofi has advised pharmacists to avoid making up the dose with 50mg and 100mg granules. If they do, it’s likely these doses will also go out of stock.

Specialist clinicians in the UK can prescribe cannabis-based medicines to people with “exceptional clinical need”

31 Oct 2018

From today, specialist clinicians can prescribe cannabis-based medicines in the UK to patients with “exceptional clinical need”. They will no longer need to apply to an expert panel for a licence.

The UK government has rescheduled cannabis-based medicines under the Misuse of Drugs regulations 2001. They are now no longer listed under Schedule 1 alongside substances considered to have no therapeutic effect.